Product Search

We provide safer and differentiated healthcare products to customers
by combining medical technologies.

PRODUCT
Synatura Syrup

Synatura Syrup

Classification
Major Ingredients Ivy leaf 30% Ethanol dried Ext. 2.625mg/mL, Coptis Rhizoma Butanol Ext. 0.875mg/mL
Efficacy/Effectiveness Relief of cough and sputum due to acute respiratory infection,chronic inflammatory bronchitis
Appearance Suspension Syrup
Print
product information

Information

1) Composition
Ivy leaf 30% Ethanol dried Ext. ---------------- 2.625mg/mL
Coptis Rhizoma Butanol Ext. ------------------ 0.875mg/mL

2) Dosage & Administration
- 2~6 year: 5ml one time
- 7~14 year: 10ml one time
- Over 15 year: 15ml one time
3) Storage
Preserve in tight containes. Store at room temperature(1-30¡É).
36 months from manufactured date.


4)Package
100mL, 150mL, 200mL, 500mL bottle,
10mL, 15mL Pouch(Sachet)

Details

[Precautions for Use]

1. Do not administer to the following patients.
1) A person who shows intolerance to this medication and its components
2) Fructose non-tolerant (containing sweetening substance sorbitol or fructose components).

2. Be careful with the following patients.
1) gastritis or gastric ulcer
2) Severe respiratory diseases such as pneumonia, uncontrolled asthma, viral flu, and tuberculosis
3) Malicious tumors, major central nervous system diseases, and other serious metabolic diseases that require medication
4) In case of severe heart failure, such as heart failure
5) Severe abnormalities in the function and function of the liver.
6) Severe diabetes that is not regulated or severe hypertension
7) A patient suffering from diarrhea, hematosis, or mucous membrane that accompanies fever

3. Adverse reations
The abnormal responses of each of the developed areas in 118 patients who received the medication were shown in the third phase of a clinical test involving 235 patients with acute upper airway infections and chronic inflammatory bronchitis in Korea were as follows. Note that the adverse events do not reveal all of the causal relationships with the drugs used in clinical trials, such as zone (0.9 %), vomiting (0.9 %), and so forth.
1) Digestion : Diarrhea (2.5 %), indigestion (2.5 %), stomach pain (2.5 %), vomiting (1.7 %), nausea (0.9 %)
2) The nervous system : Headaches (1.7 %), dizziness (0.9 %), and pharynx neurosis (0.9 %)
3) Respiratory system : sore throat (0.9 %), rhinopnea (0.9 %), upper respiratory tract pain (0.9 %), and voice change (0.9 %)
4) Other abnormal reactions : fever, muscle pain, skin exfoliation, itching, hives, etc.

4.
1) Observe the prescribed usage and capacity.
2) In case of use on children, use it under the guidance and supervision of the caregiver.

5. Interaction
No clinical experience with combination therapy with other drugs, but given the characteristics of the components of this drug, the following are true :
Interactions with medications may appear, so administer them with care.
1) Precipitation containing codeine, dextromethorphan, and other ingredients
2) Stomach pain relievers

6. Administration for pregnant women, pregnant women, fertile women, and newly-born babies
They say that they need a doctor because they have little clinical experience with pregnant women, the hydrophilia, the infant.

Use it only when judging.
7. Administration of children and children
Since there is little clinical use experience for infants less than 24 months old, the medication is administered only when the physician decides it is necessary.

8. Administration for the Elderly
Since there is little clinical use experience for older people over the age of 75, it is administered only when the physician decides it is necessary.

9. Storage and Payment Precautions
1) Keep it out of reach of children.
2) Avoid direct sunlight and store in a cool place with as little moisture as possible (Keep it closed after use.)
3) Since taking the medication out of the original container and storing it in another container may cause accidents caused by misuse of the medication, put it in the original container and close it.